Acts within the intestine, with minimal systemic absorption
Manufactured at a WHO-GMP certified facility under GLP and ISO norms
Every batch quality tested in-house before dispatch
Indications of Gluvog-0.3
Type 2 diabetes mellitus
Type 2 diabetes inadequately controlled on diet and exercise
Postprandial hyperglycaemia
How Gluvog-0.3 works
Alpha-glucosidase inhibitors act in the small intestine. They block the enzymes that break complex carbohydrates down into absorbable sugars, so glucose enters the bloodstream more slowly and the sharp rise after a meal is flattened rather than blocked.
Why ChooseGluvog-0.3?
Manufactured at a WHO-GMP certified facility under GLP, ISO and GMP norms, with raw material from approved vendors and in-house quality testing on every batch. Offered to PCD franchise partners on district-wise monopoly rights, with pan-India supply and complete promotional support.
Frequently asked questions about Gluvog-0.3
Is monopoly available for this product?
Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.
What is the composition of Gluvog-0.3?
Voglibose 0.3 mg.
Is this manufactured at a WHO-GMP certified facility?
Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is quality tested in-house before dispatch.
What is the minimum order quantity?
Please contact our team for the current MOQ and price structure for your territory.
Last updated on 29 August 2026
This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.